Hansa Biopharma is a startup based in Sweden.
Hansa Biopharma develops immunomodulating therapies using proprietary antibody-cleaving enzymes to treat rare autoimmune diseases and enable desensitization in gene therapy and transplantation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.